The potential of exogenous replacement therapy in su surfactant-defici
ent states such as neonatal respiratory distress syndrome (RDS) is an
area of intense clinical interest today. At present, a fundamental pro
blem with any type of exogenous surfactant is the uncertainty about po
tential effects on physiological defense mechanisms, such as different
iation and mobilization of peripheral leukocytes. Considering that new
born infants with proven bacterial infections have abnormal values of
segmented (neutrophil) and nonsegmented (band) polymorphonuclear leuko
cytes, we studied 42 placebo- versus Curosurf-treated babies with seve
re RDS. Differential white blood cell (WBC) count was serially perform
ed before and after treatment during the first days of lifer The stati
stically significant increase in the proportion of bands in surfactant
-treated babies did not coincide with clinical and bacteriologic evide
nce of possible infection. Some molecular interaction mechanisms influ
encing immature to mature WBC ratio are supposed. Among a variety of i
nfluences on the leukocyte count, surfactant replacement therapy needs
to be considered for proper interpretation of hematologic data in bab
ies treated for RDS.